• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位和异位患者来源的胰腺癌异种移植瘤与原始患者肿瘤的基因和代谢比较。

Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors.

作者信息

Jun Eunsung, Hong Seung-Mo, Yoo Hyun Ju, Kim Moon-Bo, Won Ji Sun, An Soyeon, Shim In Kyong, Chang Suhwan, Hoffman Robert M, Kim Song Cheol

机构信息

Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea.

Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul, South Korea.

出版信息

Oncotarget. 2017 Dec 21;9(8):7867-7881. doi: 10.18632/oncotarget.23567. eCollection 2018 Jan 30.

DOI:10.18632/oncotarget.23567
PMID:29487698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5814265/
Abstract

Tumors from 25 patients with pancreatic cancer were used to establish two patient-derived xenograft (PDX) models: orthotopic PDX (PDOX) and heterotopic (subcutaneous) PDX (PDHX). We compared gene expression by immunohistochemistry, single-nucleotide polymorphism (SNP), DNA methylation, and metabolite levels. The 4 cases, of the total of 13 in which simultaneous PDHX & PDOX models were established, were randomly selected. The molecular-genetic characteristics of the patient's tumor were well maintained in the two PDX models. SNP analysis demonstrated that both groups were more than 90% identical to the original patient's tumor, and there was little difference between the two models. DNA methylation of most genes was similar among the two models and the original patients tumor, but some gene sets were hypermethylated the in PDOX model and hypomethylated in the PDHX model. Most of the metabolites had a similar pattern to those of the original patient tumor in both PDX tumor models, but some metabolites were more prominent in the PDOX and PDHX models. This is the first simultaneous molecular-genetic and metabolite comparison of patient tumors and their tumors established in PDOX and PDHX models. The results indicate high fidelity of these critical properties of the patient tumors in the two models.

摘要

来自25例胰腺癌患者的肿瘤被用于建立两种患者来源的异种移植(PDX)模型:原位PDX(PDOX)和异位(皮下)PDX(PDHX)。我们通过免疫组织化学、单核苷酸多态性(SNP)、DNA甲基化和代谢物水平比较基因表达。在总共13例同时建立了PDHX和PDOX模型的病例中,随机选择了4例。患者肿瘤的分子遗传特征在两种PDX模型中得到了很好的保留。SNP分析表明,两组与原始患者肿瘤的相似度均超过90%,两种模型之间差异不大。两种模型与原始患者肿瘤中大多数基因的DNA甲基化相似,但一些基因集在PDOX模型中高甲基化,在PDHX模型中低甲基化。在两种PDX肿瘤模型中,大多数代谢物的模式与原始患者肿瘤相似,但一些代谢物在PDOX和PDHX模型中更为突出。这是首次对患者肿瘤及其在PDOX和PDHX模型中建立的肿瘤进行同时的分子遗传和代谢物比较。结果表明这两种模型中患者肿瘤的这些关键特性具有高保真度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967e/5814265/c1034125e34f/oncotarget-09-7867-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967e/5814265/4ce86cd83653/oncotarget-09-7867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967e/5814265/dc4fc098676c/oncotarget-09-7867-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967e/5814265/fe2f43010810/oncotarget-09-7867-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967e/5814265/c1034125e34f/oncotarget-09-7867-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967e/5814265/4ce86cd83653/oncotarget-09-7867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967e/5814265/dc4fc098676c/oncotarget-09-7867-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967e/5814265/fe2f43010810/oncotarget-09-7867-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967e/5814265/c1034125e34f/oncotarget-09-7867-g004.jpg

相似文献

1
Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors.原位和异位患者来源的胰腺癌异种移植瘤与原始患者肿瘤的基因和代谢比较。
Oncotarget. 2017 Dec 21;9(8):7867-7881. doi: 10.18632/oncotarget.23567. eCollection 2018 Jan 30.
2
A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.一种新型的食管腺癌患者来源的原位异种移植模型为转化研究提供了一个平台。
Dis Model Mech. 2019 Dec 17;12(12):dmm041004. doi: 10.1242/dmm.041004.
3
Patient-derived orthotopic xenograft (PDOX) nude mouse model of soft-tissue sarcoma more closely mimics the patient behavior in contrast to the subcutaneous ectopic model.与皮下异位模型相比,软组织肉瘤的患者来源原位异种移植(PDOX)裸鼠模型更能紧密模拟患者的病情表现。
Anticancer Res. 2015 Feb;35(2):697-701.
4
Patient-derived mouse models of cancer need to be orthotopic in order to evaluate targeted anti-metastatic therapy.为了评估靶向抗转移治疗,源自患者的癌症小鼠模型需要是原位的。
Oncotarget. 2016 Nov 1;7(44):71696-71702. doi: 10.18632/oncotarget.12322.
5
Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples.转移性胰腺癌患者来源的临床前平台的开发:人源肿瘤异种移植模型及后续使用经皮活检样本的类器官模型系统
Front Oncol. 2019 Sep 13;9:875. doi: 10.3389/fonc.2019.00875. eCollection 2019.
6
High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy.患者来源的原位异种移植(PDOX)小鼠模型中耐药性的高临床一致性:验证精准个体化癌症化疗的第一步。
Anticancer Res. 2023 Oct;43(10):4277-4284. doi: 10.21873/anticanres.16622.
7
Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern.建立表达临床转移模式的HER-2阳性宫颈癌患者来源的原位异种移植(PDOX)模型。
PLoS One. 2015 Feb 17;10(2):e0117417. doi: 10.1371/journal.pone.0117417. eCollection 2015.
8
Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.宫颈癌患者来源的原位异种移植瘤(PDOX)对顺铂敏感,对纳米白蛋白结合型紫杉醇耐药。
Anticancer Res. 2017 Jan;37(1):61-65. doi: 10.21873/anticanres.11289.
9
Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma.原发性和复发性脑膜瘤的患者来源原位异种移植(PDOX)小鼠模型
Cancers (Basel). 2020 Jun 5;12(6):1478. doi: 10.3390/cancers12061478.
10
Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer.患者来源的异种移植模型:胰腺癌临床和临床前研究的宝贵平台。
Chin Clin Oncol. 2019 Apr;8(2):17. doi: 10.21037/cco.2019.02.04. Epub 2019 Apr 3.

引用本文的文献

1
Multiparametric Magnetic Resonance Imaging and Metabolic Characterization of Patient-Derived Xenograft Models of Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌患者来源异种移植模型的多参数磁共振成像与代谢特征分析
Metabolites. 2022 Nov 15;12(11):1117. doi: 10.3390/metabo12111117.
2
Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunotherapy.原位和异位胰腺癌细胞小鼠模型表现出不同的免疫微环境,并对免疫治疗有不同的反应。
Front Immunol. 2022 Jul 7;13:863346. doi: 10.3389/fimmu.2022.863346. eCollection 2022.
3
Canine and murine models of osteosarcoma.

本文引用的文献

1
Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.替莫唑胺联合伊立替康在一个源自成年多形性横纹肌肉瘤患者的原位异种移植(PDOX)裸鼠模型中引起了肿瘤消退。
Oncotarget. 2017 Mar 24;8(44):75874-75880. doi: 10.18632/oncotarget.16548. eCollection 2017 Sep 29.
2
Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.在患者来源的原位异种移植(PDOX)模型中,鼠伤寒沙门氏菌A1-R对化疗耐药的BRAF-V600E黑色素瘤的靶向作用,与维莫非尼或替莫唑胺联合使用时增强。
Cell Cycle. 2017 Jul 3;16(13):1288-1294. doi: 10.1080/15384101.2017.1314420. Epub 2017 Jun 16.
3
犬和鼠骨肉瘤模型。
Vet Pathol. 2022 May;59(3):399-414. doi: 10.1177/03009858221083038. Epub 2022 Mar 26.
4
Potential impact of tissue molecular heterogeneity on ambient mass spectrometry profiles: a note of caution in choosing the right disease model.组织分子异质性对环境质谱分析谱的潜在影响:在选择合适疾病模型时应谨慎。
Anal Bioanal Chem. 2021 Apr;413(10):2655-2664. doi: 10.1007/s00216-020-03054-0. Epub 2020 Nov 27.
5
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.通过表达微阵列建立和鉴定患者来源的人胰腺导管腺癌异种移植panel。
Int J Mol Sci. 2020 Jan 31;21(3):962. doi: 10.3390/ijms21030962.
6
Genetically Engineered Pigs to Study Cancer.基因工程猪用于癌症研究。
Int J Mol Sci. 2020 Jan 13;21(2):488. doi: 10.3390/ijms21020488.
7
Generation and application of patient-derived xenograft models in pancreatic cancer research.患者来源异种移植模型在胰腺癌研究中的产生和应用。
Chin Med J (Engl). 2019 Nov 20;132(22):2729-2736. doi: 10.1097/CM9.0000000000000524.
8
Serial patient-derived orthotopic xenografting of adenoid cystic carcinomas recapitulates stable expression of phenotypic alterations and innervation.连续的患者来源的腺样囊性癌原位异种移植重现了表型改变和神经支配的稳定表达。
EBioMedicine. 2019 Mar;41:175-184. doi: 10.1016/j.ebiom.2019.02.011. Epub 2019 Feb 11.
MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX).MEK抑制剂考比替尼和曲美替尼使一名吉西他滨耐药的胰腺癌患者来源的原位异种移植瘤(PDOX)消退。
Oncotarget. 2017 Jul 18;8(29):47490-47496. doi: 10.18632/oncotarget.17667.
4
Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.经动脉内给予肿瘤靶向鼠伤寒沙门氏菌 A1-R 可使顺铂耐药复发性骨肉瘤在患者来源的原位异种移植(PDOX)小鼠模型中消退。
Cell Cycle. 2017 Jun 18;16(12):1164-1170. doi: 10.1080/15384101.2017.1317417. Epub 2017 May 11.
5
Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model.在一个可成像的患者来源原位异种移植(iPDOX)模型中,吉西他滨和多西他赛联合使用可抑制胃平滑肌肉瘤的增殖和侵袭。
Cell Cycle. 2017 Jun 3;16(11):1063-1069. doi: 10.1080/15384101.2017.1314406. Epub 2017 Apr 20.
6
Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.重组蛋氨酸酶在患者来源的原位异种移植(PDOX)裸鼠模型中有效靶向尤因肉瘤。
Oncotarget. 2017 May 30;8(22):35630-35638. doi: 10.18632/oncotarget.15823.
7
The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago.尤因肉瘤患者源性原位异种移植(PDOX)模型的高效细菌疗法具有讽刺意味,该疗法在80年前就被尤因本人阻止了。
Cell Cycle. 2017 Jun 3;16(11):1046-1052. doi: 10.1080/15384101.2017.1304340. Epub 2017 Mar 15.
8
High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.通过患者来源的原位异种移植(PDOX)裸鼠模型确定帕唑帕尼对一线治疗耐药的未分化梭形细胞肉瘤具有高效性。
J Cell Biochem. 2017 Sep;118(9):2739-2743. doi: 10.1002/jcb.25923. Epub 2017 Apr 25.
9
Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.肿瘤靶向性鼠伤寒沙门氏菌A1-R在患者来源的原位异种移植(PDOX)裸鼠模型中使携带BRAF-V600E突变的黑色素瘤对维莫非尼敏感。
J Cell Biochem. 2017 Aug;118(8):2314-2319. doi: 10.1002/jcb.25886. Epub 2017 Apr 25.
10
Reconstitution of a metastatic-resistant tumor microenvironment with cancer-associated fibroblasts enables metastasis.癌症相关成纤维细胞重建转移性抗性肿瘤微环境可促进转移。
Cell Cycle. 2017 Mar 19;16(6):533-535. doi: 10.1080/15384101.2017.1281486. Epub 2017 Jan 19.